Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The company’s ...

The drug manufacturer Amgen announced Thursday it will invest another $1 billion and add 370 jobs to its future facility in ...

Furthermore, the biotech's dividend program remains compelling despite near-term headwinds. Therefore, Amgen's combination of ...

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...

State and local officials are poised to announce a major economic development deal -- one that could bring hundreds of jobs ...

Amgen (AMGN) announced new data from a Phase 3 study demonstrating that adding BLINCYTO (blinatumomab) to chemotherapy significantly ...

Biopharma company Amgen plans to add 370 jobs as part of a new, $1.02 billion investment in Holly Springs. It’s the latest ...

Amgen’s decision to locate – and now expand – in Holly Springs fortifies the town’s and state’s reputations as ...

U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in ...

The board of Amgen boosted its quarter dividend by almost 6%. The Thousand Oaks, Calif.-based biotechnology company said Tuesday that it raised its dividend to $2.38 per share for the first quarter, ...

Amgen appointed Naveen Gullapalli, former Novartis executive, as Managing Director of Amgen India. Gullapalli will lead Amgen ...

The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard ...